Biote Corp Financials

BTMD Stock  USD 6.10  0.10  1.61%   
Based on the analysis of Biote Corp's profitability, liquidity, and operating efficiency, biote Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Biote Corp's Other Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 107.5 M, whereas Other Current Liabilities is forecasted to decline to about 6.7 M. Key indicators impacting Biote Corp's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.01950.0206
Notably Down
Slightly volatile
Return On Assets0.02330.0246
Notably Down
Slightly volatile
Current Ratio2.784.96
Way Down
Slightly volatile
Investors should never underestimate Biote Corp's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Biote Corp's cash flow, debt, and profitability to make informed and accurate decisions about investing in biote Corp.

Net Income

2.84 Million

  
Understanding current and past Biote Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biote Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Biote Corp's assets may result in an increase in income on the income statement.

biote Corp Earnings Geography

Please note, the presentation of Biote Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biote Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biote Corp's management manipulating its earnings.

Biote Corp Stock Summary

Biote Corp competes with Encompass Health, Pennant, Ensign, InnovAge Holding, and ModivCare. biote Corp. operates in medical practice-building business within the hormone optimization space. The company was founded in 2011 and is headquartered in Irvine, Texas. Biote Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0906831039
CUSIP090683103 42087R108
LocationTexas; U.S.A
Business Address1875 W Walnut
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitebiote.com
Phone844 604 1246
CurrencyUSD - US Dollar

Biote Corp Key Financial Ratios

Biote Corp Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets32.6M54.3M111.6M155.3M178.6M187.5M
Other Current Liab4.0M7.6M5.1M8.5M9.8M6.7M
Net Debt25.1M10.6M41.2M25.9M23.3M22.3M
Retained Earnings(17.1M)4.2M(44.5M)(29.4M)(26.5M)(27.8M)
Accounts Payable2.4M4.3M4.1M4.2M4.8M4.0M
Cash17.2M26.8M79.2M89.0M102.4M107.5M
Net Receivables4.7M5.2M6.9M8.2M9.4M6.4M
Inventory4.3M9.6M11.2M20.9M24.1M25.3M
Other Current Assets1.6M5.5M3.8M4.2M4.9M3.5M
Total Liab49.7M50.2M169.9M191.8M220.6M114.1M
Total Current Assets27.8M47.1M101.2M122.3M140.7M147.7M
Short Term Debt5.2M5.2M6.6M6.6M7.5M6.3M
Intangible Assets2.6M4.6M5.1M5.0M5.7M4.2M

Biote Corp Key Income Statement Accounts

202020212022202320242025 (projected)
Tax Provision189K286K388K5.9M6.7M7.1M
Net Interest Income(2.4M)(1.7M)(5.1M)(7.4M)(6.7M)(6.4M)
Interest Expense2.4M1.7M5.1M6.4M7.3M3.9M
Total Revenue116.6M139.4M165.0M185.4M213.2M157.6M
Gross Profit71.6M90.6M110.4M127.5M146.6M102.6M
Operating Income31.8M34.6M(60.7M)28.7M25.8M27.1M
Ebit31.8M34.6M6.8M6.2M5.6M5.3M
Ebitda32.9M36.0M9.2M9.2M8.3M7.9M
Cost Of Revenue44.9M48.8M54.6M57.9M66.6M54.9M
Income Before Tax29.4M32.9M1.7M(123K)(110.7K)(105.2K)
Net Income29.2M32.6M1.3M3.3M3.0M2.8M
Income Tax Expense189K286K388K2.7M3.1M3.2M

Biote Corp Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(904K)(5.8M)(1.7M)(6.1M)(5.5M)(5.2M)
Investments(1.4M)(3.8M)(1.8M)(22.0M)(19.8M)(18.8M)
Change In Cash6.7M9.6M52.5M9.8M11.2M19.5M
Free Cash Flow25.0M29.9M(11.0M)24.2M21.8M14.7M
Depreciation1.1M1.4M2.2M3.0M3.4M1.9M
Other Non Cash Items1.7M1.2M(58.3M)19.7M17.7M18.6M
Dividends Paid13.3M11.4M12.9M8.7M7.8M7.4M
Capital Expenditures1.4M3.8M1.8M2.7M3.1M2.5M
Net Income29.2M32.6M1.3M3.3M3.0M2.8M
End Period Cash Flow17.2M26.8M79.2M89.0M102.4M107.5M

Biote Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Biote Corp's current stock value. Our valuation model uses many indicators to compare Biote Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biote Corp competition to find correlations between indicators driving Biote Corp's intrinsic value. More Info.
biote Corp is number one stock in return on asset category among its peers. It is rated fifth in profit margin category among its peers fabricating about  0.20  of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for biote Corp is roughly  4.88 . At present, Biote Corp's Net Profit Margin is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biote Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

biote Corp Systematic Risk

Biote Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biote Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on biote Corp correlated with the market. If Beta is less than 0 Biote Corp generally moves in the opposite direction as compared to the market. If Biote Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one biote Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biote Corp is generally in the same direction as the market. If Beta > 1 Biote Corp moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Biote Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biote Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Biote Corp growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(2.23)

At present, Biote Corp's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

Biote Corp January 7, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Biote Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of biote Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of biote Corp based on widely used predictive technical indicators. In general, we focus on analyzing Biote Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biote Corp's daily price indicators and compare them against related drivers.

Complementary Tools for Biote Stock analysis

When running Biote Corp's price analysis, check to measure Biote Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biote Corp is operating at the current time. Most of Biote Corp's value examination focuses on studying past and present price action to predict the probability of Biote Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biote Corp's price. Additionally, you may evaluate how the addition of Biote Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
CEOs Directory
Screen CEOs from public companies around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance